title: Reply to "at the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection".
authors.affiliation: Municipal Health Secretariat, Rio de Janeiro, RJ, Brazil. Electronic address: valsaraceni@gmail.com.
authors.forename: Valeria
authors.initials: V
authors.lastname: Saraceni
authors.affiliation: Municipal Health Secretariat, Rio de Janeiro, RJ, Brazil; Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
authors.forename: Betina
authors.initials: B
authors.lastname: Durovni
authors.affiliation: Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.
authors.forename: Antonio Guilherme
authors.initials: AG
authors.lastname: Pacheco
authors.affiliation: Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, United States.
authors.forename: Richard E
authors.initials: RE
authors.lastname: Chaisson
authors.affiliation: Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, United States; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.
authors.forename: Jonathan E
authors.initials: JE
authors.lastname: Golub
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000401:mortality*; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D006801:Humans; D008297:Male; D014376:Tuberculosis / Q000401:mortality*
references.citation: N Engl J Med. 2010 Feb 25;362(8):697-706
references.pmid: 20181971
references.citation: Lancet Infect Dis. 2013 Oct;13(10):852-8
references.pmid: 23954450
references.citation: Braz J Infect Dis. 2014 Sep-Oct;18(5):491-5
references.pmid: 24780362
references.citation: Lancet Infect Dis. 2014 Jul;14(7):563-71
references.pmid: 24810491